RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
- Posted on April 16, 2026
- By CNBC
- 0 Views
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the opportunity.
